Nemluvio Nemolizumab Ilto — Blue Cross Blue Shield Of New Mexico
6 indications indexed for this drug.
- Atopic DermatitisView coverage criteria
- Compendia Supported Indication For Nemolizumab Ilto And RoutView coverage criteria
- Contraindicated As Concomitant Therapy With Il 1 InhibitorsView coverage criteria
- Moderate To Severe Atopic DermatitisView coverage criteria
- Other Fda Labeled Indication For Nemolizumab Ilto And RouteView coverage criteria
- Prurigo NodularisView coverage criteria